NBC Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Hold
1,557
0.01% 1066
2026
Q1
$84.2K Buy
1,557
+1
+0.1% +$56 0.01% 1141
2025
Q4
$87.2K Sell
1,556
-216
-12% -$11.2K 0.01% 1130
2025
Q3
$85K Sell
1,772
-399
-18% -$17.8K 0.01% 1135
2025
Q2
$88K Buy
2,171
+28
+1% +$1.13K 0.01% 1107
2025
Q1
$93K Buy
2,143
+2,141
+107,050% +$94.5K 0.01% 997
2024
Q4
$100 Sell
2
-2,339
-100% -$106K 0.01% 922
2024
Q3
$103K Buy
2,341
+1
+0% +$43 0.01% 973
2024
Q2
$93K Buy
2,340
+196
+9% +$7.94K 0.01% 975
2024
Q1
$92K Buy
2,144
+1
+0% +$43 0.01% 967
2023
Q4
$89K Sell
2,143
-200
-9% -$7.58K 0.01% 976
2023
Q3
$93K Buy
+2,343
New +$99.1K 0.01% 959

Other funds holding XPH

NBC Securities's XPH Position: Q2 2026 in Review

NBC Securities held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 1,557 shares worth $103K. The position accounts for 0.01% of the portfolio, ranked #1066.

NBC Securities first reported a position in XPH in Q3 2023 and has held it in 12 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • NBC Securities held 1,557 shares of State Street SPDR S&P Pharmaceuticals ETF worth $103K as of Q2 2026.
  • NBC Securities left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of NBC Securities's portfolio in Q2 2026, its #1066 holding.
  • NBC Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2023 and has held it in 12 quarters since.
  • 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.